Purdue OTCs
This article was originally published in The Tan Sheet
Executive Summary
Stamford, Conn.-based firm announces resumed shipment of several OTC product lines after manufacturing difficulties, including Betadine microbicides, Colace stool softeners, Gentlax Tablets and Slow-Mag Tablets. "We are working hard to ensure that our full line of OTC products is back on the market and actively promoted as soon as possible, including the Senokot Laxative family of products," said Steve Seid, Exec Director-National Accounts & Trade Relations Feb. 22. Purdue acquired Colace and Slow-Mag last year to bolster consumer health business (1"The Tan Sheet" Jan. 6, 2003, p. 12)...
You may also be interested in...
Colace, Slow-Mag Buy Part Of Purdue Consumer Health Growth Plan
Purdue Pharma's acquisition of the Colace stool softener, Peri-Colace laxative capsule and Slow-Mag dietary supplement brands from Shire Pharmaceuticals Group is part of the firm's strategy to grow and diversify its consumer health business
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.